Advanced Liver Cancer Market wird von klinischen Studien (Phase III, Phase II, Phase I), By Route of Administration (Oral, Intravenous), By Molecule Type (Small Molecule, ....
Zu den wichtigsten Akteuren des Advanced Liver Cancer Market gehören Can-Fite BioPharma, Polaris Pharmaceuticals, Surface Oncology, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Exelixis, Eli Lily und Company, Genetech, Merck & Co., Qurient Co. Ltd, Teclison, Eureka Therapeutics, Bristol Myers Squibb und Ono Pharmaceuticals.
Fortgeschrittener Leberkrebsmarkt